Covid shield firm praises M-SParc
A COMPANY carrying out worldleading research into developing preventive and curative treatments for pandemic illnesses such as Covid-19 and Influenza using protein science has heaped praise on Menai Science Park on Anglesey.
Virustatic Ltd, who have used innovative protein technology to develop a snood – the Virustatic Shield – that offers up to 99% protection against respiratory viruses, are tenants at Bangor University’s M-SParc, and have recently praised the benefits of being at the Park.
Virustatic’s Lucy Hope said: “The benefit of having our HQ at M-SParc is not only the state-of-the-art facilities, but also being part of a network of all that is supportive within innovation and development in Wales. You are never far away from other likeminded people, and it is easy to feed off the buzz of the environment.
“The proximity and ease of access to the excellent academic links in Wales is also very beneficial. We are now a
BEACON project and we are working on an exciting venture with the BioComposites Centre at Bangor University, which is important to us as a company with environmental sustainability at the top of our agenda. Being at M-SParc has given us connections to organisations such as Life Sciences Hub Wales, Accelerate, BIC Innovation and CALIN who are actively supporting us in our vision to do things differently in response to new environmental challenges.”
Following the successful launch of their Virustatic Shield, the company are working with Welsh institutions to try and bring a preventative and curative COVID and influenza inhaler, based on their protein science, through to clinical trials.
M-SParc MD Pryderi ap Rhisiart added: “We were pleased to be able to make the links to BioComposites, via Bangor University. This is a great link to have, and a real benefit to our tenants that we are able to offer this type of support.”